GHERMAN, A.; CĂINAP, C.; CONSTANTIN, A.-M.; CETEAN, S.; CĂINAP, S. Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab. Medicine and Pharmacy Reports, v. 90, n. 4, p. 377-384, 30 out. 2017.